AACR RAS 2026
Mar 5 - 8, 2026 | Los Angeles, CA
The agents listed below are currently under investigation. Their safety and efficacy have not been established.
Poster
Preclinical Activity of an Orally Bioavailable PROTAC Pan-KRAS Degrader Versus Inhibitors in Mutant KRAS ModelsA Lopez-Arroyo et al.
Presentation
Preclinical Activity of an Orally Bioavailable PROTAC Pan-KRAS Degrader Versus Inhibitors in Mutant KRAS ModelsA Lopez-Arroyo